Head-To-Head Comparison: Vireo Growth (VREOD) & Its Peers

Vireo Growth (OTCMKTS:VREOD) is one of 908 publicly-traded companies in the “Pharmaceuticals” industry, but how does it contrast to its peers? We will compare Vireo Growth to similar businesses based on the strength of its profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends.

Insider and Institutional Ownership

32.9% of shares of all “Pharmaceuticals” companies are held by institutional investors. 3.8% of Vireo Growth shares are held by insiders. Comparatively, 14.2% of shares of all “Pharmaceuticals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations for Vireo Growth and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vireo Growth	1	0	0	0	1.00
Vireo Growth Competitors	7593	13671	25506	988	2.42

As a group, “Pharmaceuticals” companies have a potential upside of 29.28%. Given Vireo Growth’s peers stronger consensus rating and higher possible upside, analysts clearly believe Vireo Growth has less favorable growth aspects than its peers.

Earnings and Valuation

This table compares Vireo Growth and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Vireo Growth	$268.77 million	-$68.11 million	-3.02
Vireo Growth Competitors	$16.80 billion	$3.12 billion	511.26

Vireo Growth’s peers have higher revenue and earnings than Vireo Growth. Vireo Growth is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Vireo Growth has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500. Comparatively, Vireo Growth’s peers have a beta of -3.23, meaning that their average share price is 423% less volatile than the S&P 500.

Profitability

This table compares Vireo Growth and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vireo Growth	-23.37%	-19.76%	-7.15%
Vireo Growth Competitors	-2,478.03%	-250.55%	-16.90%

Summary

Vireo Growth peers beat Vireo Growth on 9 of the 13 factors compared.

About Vireo Growth

Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.